Search
for

    Sort by

    Research 271–300 of 661

    1. Dutasteride for the treatment of benign prostatic hyperplasia Expert opinion on pharmacotherapy · 2013 · 24 citations
    2. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    3. Primary Scarring Alopecia: Clinical-Pathological Review of 72 Cases and Review of the Literature Skin appendage disorders · 2017 · 22 citations
    4. Corn silk extract improves benign prostatic hyperplasia in experimental rat model Nutrition Research and Practice · 2017 · 20 citations
    5. Medikamentöse Therapie des benignen Prostatasyndroms Der Urologe · 2015 · 20 citations
    6. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    7. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians Asian journal of urology · 2017 · 19 citations
    8. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old British Journal of Dermatology · 2008 · 18 citations
    9. Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia Pharmaceutical biology · 2019 · 16 citations
    10. Finasterida: Diez Años De Uso Clínico. Revisión Sistemática De La Literatura Actas Urológicas Españolas · 2003 · 14 citations
    11. Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients European Urology Supplements · 2003 · 12 citations
    12. Association between prostate‐specific antigen and serum testosterone: A systematic review and meta‐analysis Andrology · 2020 · 11 citations
    13. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer Journal of The European Academy of Dermatology and Venereology · 2014 · 11 citations
    14. Preventive Effects of Monascus on Androgen-Related Diseases: Androgenetic Alopecia, Benign Prostatic Hyperplasia, and Prostate Cancer Journal of Agricultural and Food Chemistry · 2013 · 11 citations
    15. Economic Issues in the Treatment of BPH European Urology Supplements · 2006 · 11 citations
    16. Estudio de patrones de implantación pilosa frontal en la mujer española caucásica Actas Dermo-Sifiliográficas · 2013 · 10 citations
    17. Abiraterone and spironolactone in prostate cancer: a combination to avoid Acta Clinica Belgica · 2018 · 9 citations
    18. Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice PLOS ONE · 2013 · 9 citations
    19. THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction? Dermatologic Therapy · 2010 · 9 citations
    20. Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping Clinical Chemistry · 2016 · 8 citations
    21. 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice European Urology · 2013 · 7 citations
    22. The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study The Aging Male · 2020 · 6 citations
    23. Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer Neoplasma · 2010 · 6 citations
    24. Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention Journal of Clinical Oncology · 2009 · 6 citations
    25. Prostate cancer update: 2007 Current Opinion in Oncology · 2008 · 6 citations
    26. 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy Zenodo (CERN European Organization for Nuclear Research) · 2026 · 6 citations
    27. Long-Term Experience With 5-alpha-Reductase Inhibitors. PubMed · 2003 · 6 citations
    28. Inhibitory effects of TripTripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats 2015 · 5 citations
    29. Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels PloS one · 2018 · 4 citations
    30. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States 2016 · 4 citations